ACO Name and Location

The Accountable Care Organization, Ltd.
950 N Glebe Rd
Suite 700
Arlington, VA 22203
USA

ACO Primary Contact

Sam Starbuck
Phone: 571-366-8850 
Email: sstarbuck@priviahealth.com
 

Organizational Information

ACO Participants:

ACO Governing Body:

* –Member’s voting power may have been rounded to reflect a total voting power of 100 percent.

Key ACO Clinical and Administrative Leadership:

• ACO Executive: Sam Starbuck
• Medical Director: Douglas Short, MD
• Compliance Officer: Stephanie Clark
• Quality Assurance/Improvement Officer: Douglas Short, MD

Associated Committees and Committee Leadership:

Types of ACO participants, or combinations of participants, that formed the ACO:

• ACO professionals in a group practice arrangements
• Networks of individual practices of ACO professionals.

Shared Savings and Losses

Amount of Shared Savings / Losses:

• Third Agreement Period
  • Performance Year 2024: $42,613,982.71
  • Performance Year 2023: $47,640,428.33
  • Performance Year 2022: $40,591,383.00
  • Performance Year 2021: $16,167,038.65
  • Performance Year 2020: $15,769,603.93
• Second Agreement Period
  • Performance Year 2019: $0.00
  • Performance Year 2018: $0.00
  • Performance Year 2017: N/A
• First Agreement Period
  • Performance Year 2016: $10,544,665.35
  • Performance Year 2015: N/A
  • Performance Year 2014: $4,439,150.60

Shared Savings Distribution

• Third Agreement Period
  • Performance Year 2024
    • Proportion invested in infrastructure: 10%
    • Proportion invested in redesigned care processes/resources: 30%
    • Proportion of distribution to ACO participants: 60%
  • Performance Year 2023
    • Proportion invested in infrastructure: 10%
    • Proportion invested in redesigned care processes/resources: 30%
    • Proportion of distribution to ACO participants: 60%
  • Performance Year 2022
    • Proportion invested in infrastructure: 10%
    • Proportion invested in redesigned care processes/resources: 30%
    • Proportion of distribution to ACO participants: 60%
  • Performance Year 2021
    • Proportion invested in infrastructure: 10%
    • Proportion invested in redesigned care processes/resources: 35%
    • Proportion of distribution to ACO participants: 55%
  • Performance Year 2020
    • Proportion invested in infrastructure: 10%
    • Proportion invested in redesigned care processes/resources: 35%
    • Proportion of distribution to ACO participants: 55%
• Second Agreement Period
  • Performance Year 2019
    • Proportion invested in infrastructure: N/A
    • Proportion invested in redesigned care processes/resources: N/A
    • Proportion of distribution to ACO participants: N/A
  • Performance Year 2018
    • Proportion invested in infrastructure: N/A
    • Proportion invested in redesigned care processes/resources: N/A
    • Proportion of distribution to ACO participants: N/A
  • Performance Year 2017
    • Proportion invested in infrastructure: N/A
    • Proportion invested in redesigned care processes/resources: N/A
    • Proportion of distribution to ACO participants: N/A
• First Agreement Period
  • Performance Year 2016
    • Proportion invested in infrastructure: 10%
    • Proportion invested in redesigned care processes/resources: 40%
    • Proportion of distribution to ACO participants: 50%
  • Performance Year 2015
    • Proportion invested in infrastructure: N/A
    • Proportion invested in redesigned care processes/resources: N/A
    • Proportion of distribution to ACO participants: N/A
  • Performance Year 2014
    • Proportion invested in infrastructure: 10%
    • Proportion invested in redesigned care processes/resources: 40%
    • Proportion of distribution to ACO participants: 50%

Quality Performance Results

2024 Quality Performance Results:

Quality Performance Results are based on CMS Web Interface Measure Set

• For Diabetes: Hemoglobin A1c (HbA1c) Poor Control (>9%) [Quality ID #001], Hospital-Wide, 30-Day, All-Cause Unplanned Readmission (HWR) Rate for MIPS Eligible Clinician Groups [Measure #479], and Clinician and Clinician Group Risk-standardized Hospital Admission Rates for Patients with Multiple Chronic Conditions (MCC) [Measure #484], a lower performance rate indicates better measure performance.
• For Clinician and Clinician Group Risk-standardized Hospital Admission Rates for Patients with Multiple Chronic Conditions (MCC) [Measure #484], patients are excluded if they were attributed to Qualifying Alternative Payment Model (APM) Participants (QPs). Most providers participating in Track E and ENHANCED track ACOs are QPs, and so performance rates for Track E and ENHANCED track ACOs may not be representative of the care provided by these ACOs' providers overall. Additionally, many of these ACOs do not have a performance rate calculated due to not meeting the minimum of 18 beneficiaries attributed to non-QP providers.

For Previous Years’ Financial and Quality Performance Results, Please Visit data.cms.gov

Payment Rule Waivers

• Skilled Nursing Facility (SNF) 3-Day Rule Waiver
  • Our ACO uses the SNF 3-Day Rule Waiver, pursuant to 42 CFR § 425.612.